Study protocol for using a smartphone application to investigate speech biomarkers of Parkinson’s disease and other synucleinopathies: SMARTSPEECH
Introduction Early identification of Parkinson’s disease (PD) in its prodromal stage has fundamental implications for the future development of neuroprotective therapies. However, no sufficiently accurate biomarkers of prodromal PD are currently available to facilitate early identification. The voca...
Saved in:
Main Authors: | Jan Rusz, Tomáš Kouba, Vojtěch Illner |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e059871.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies
by: Kazunari Sekiyama, et al.
Published: (2012-01-01) -
Enhancing sleep quality in synucleinopathies through physical exercise
by: Jacopo Canonichesi, et al.
Published: (2025-01-01) -
Magnetic susceptibility components reveal different aspects of neurodegeneration in alpha-synucleinopathies
by: Oliver C. Kiersnowski, et al.
Published: (2025-02-01) -
Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
by: Grace Kuo, et al.
Published: (2025-01-01) -
Erectile Dysfunction Preceding Clinically Diagnosed α-Synucleinopathies: A Case-Control Study in Olmsted County
by: Shemonti Hasan, et al.
Published: (2019-01-01)